Dishman Pharmaceuticals & Chemicals (Delisted) MD, chairman, board of directors and AGM

BSE: 532526

Last traded ₹301.20 on 29 May 2017

Delisted on 8 Jan 2018.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 27 Sep 2016, 2 fund houses

  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    Against LIC Mutual Fund
    • LIC Mutual FundCompliant with law, governance concern: Same person as MD and Chairman. Concentration of power.
    0 for1 against
  • Adoption of standalone and consolidated financial statements for the year ended 31 March 2016
    0 for0 against

    1 abstained

  • Fix commission for non-executive directors for the next two years at an amount not exceeding 1% of net profits
    0 for0 against

    1 abstained

  • Ratify V. D. Shukla & Co. and Haribhakti & Co. LLP’s appointment as joint statutory auditors and fix their remuneration
    0 for0 against

    1 abstained

  • Reappoint Janmejay R. Vyas as an Executive Director
    0 for0 against

    1 abstained

  • To confirm interim dividend of Rs.2.0 per equity share (face value Rs.2.0)
    0 for0 against

    1 abstained

Mutual fund votes, meeting of 5 Aug 2016, 1 fund house

  • Item 1, as a fund house numbered it
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.